AdventNet today announced that Vectura, an emerging pharmaceutical
company in the UK producing pulmonary products for healing lung
diseases, is using ManageEngine OpManager to proactively monitor
its network infrastructure. To learn more on why thousands of organizations
rely on OpManager for their network monitoring needs, visit: www.opmanager.com
When you run a business that has the potential to help millions
of lives, you want IT processes to operate at the maximum possible
efficiency. At Vectura, helping people is a full time commitment.
The company has undertaken massive research and development efforts
to produce inhaled drugs for the treatment of lung diseases, which
significantly reduce the cost of treatment to millions of patients.
Vectura wanted a near perfect network infrastructure that supported
all of its research initiatives.
"With state-of-the-art research gadgets and high end technology
utilities, our research labs host a majority of our workforce. For
them to be able to work hassle free, we wanted to provide them with
infrastructure that is highly reliable and available all the time,"
said Ian Attenburrow, Systems Administrator at Vectura Group Plc.
"We have been fiddling with Network hardware and related technologies
for years and have finally found OpManager - an easy to use, cost-effective
tool that proactively manages our entire infrastructure." he
added.
Vectura chose OpManager after a rigorous evaluation process earlier
this year. OpManager automatically discovers Vectura's network devices
including: Avaya and Dell switches, server room weather sensors,
numerous laser printers, and consolidates them in one single dashboard.
Out-of-the-box features, responsible support and affordable pricing
make OpManager a favorite choice of numerous healthcare organizations
like Vectura.
"Currently, numerous cutting-edge healthcare organizations
around the globe are using OpManager," said Girish Mathrubootham,
Product Manager at AdventNet. "We are proud to have a rapidly
emerging company like Vectura as our customer. It's exciting to
know that our product surpassed their rigorous evaluation and emerged
as the preferred choice over many other tools," he added.
About Vectura
Vectura's (LSE: VEC) principal focus is to combine its proprietary
pulmonary formulation and device technologies with existing, off-patent
drugs to develop inhaled drugs for the treatment of both lung diseases
and conditions where delivery via the lungs can provide significant
benefits, such as a rapid onset of action, improved efficacy and
improved tolerability compared with current therapies.
The Company will seek to license its lead products to pharmaceutical
companies with established sales and marketing infrastructures for
the later stages of development and for commercialization, typically
prior to Phase III clinical development. The Company has development
collaborations with a number of companies, including GSK, Chiesi
and Arakis. For further information, please visit Vectura's website
at www.vectura.com
About AdventNet
Enabling Management Your Way™
AdventNet provides affordable software in the areas of network
applications and database tools. With a broad product portfolio
and an active customer base ranging from enterprises, equipment
vendors and service providers, AdventNet has emerged as a very affordable
and high-quality alternative to expensive software that is common
in the industry. AdventNet is headquartered in Pleasanton, CA with
offices in NJ, NH, India, UK, China and Japan. It has a well-trained
partner base around the globe and thousands of customers world-wide.
Visit us at www.adventnet.com.
Contact:
Gary Raj, Media Relations
AdventNet, Inc.
(925) 965-6272 gary@adventnet.com
